Sayanan Chowsilpa

Sayanan Chowsilpa

Auto-generated profile, based on publicly available information

Sayanan Chowsilpa

Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in Annals of Coloproctology
Verified
Journal Article
Open access
WVWITCHA VIPUDHAMORN
WITCHA VIPUDHAMORN
TJTawan Juthasilaparut
Tawan Juthasilaparut
PSPawit Sutharat
Pawit Sutharat
SSSuwan Sanmee
Suwan Sanmee
ESEkkarin Supatrakul
Ekkarin Supatrakul
RRRujee Rattanasathien
Rujee Rattanasathien
Sclerosing encapsulating peritonitis (SEP) is a rare but serious condition characterized by the progressive formation of a dense fibrous sheath encasing the small bowel within the peritoneal cavity. This review provides a comprehensive overview of the current understanding of SEP, focusing on its etiology, clinical presentation, diagnostic modalities, and management strategies. SEP can be classified into primary and secondary forms, each with distinct etiologies and treatment approaches. Primary SEP typically presents with acute or subacute bowel obstruction symptoms, necessitating surgical intervention to excise the fibrous sheath and relieve the obstruction. Secondary SEP often occurs in patients undergoing peritoneal dialysis, with cessation of dialysis being a key component of management. Medical treatments, including corticosteroids, immunosuppressive agents, and nutritional support, may complement surgical intervention, particularly in cases of secondary SEP. Advanced imaging techniques and personalized medicine approaches show promise in improving diagnostic accuracy and tailoring treatment strategies to individual patients. Future research directions include investigating targeted pharmacological therapies, exploring minimally invasive surgical techniques, and conducting long-term follow-up studies to evaluate treatment efficacy and disease recurrence. Multidisciplinary care teams play a crucial role in the comprehensive management of SEP, emphasizing collaboration among various specialties to optimize patient outcomes.

15 July 2020 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
SCSayanan Chowsilpa
Sayanan Chowsilpa
RJRobert Jones
Robert Jones
JHJen-Fan Hang
Jen-Fan Hang
SASyed Z. Ali
Syed Z. Ali

30 January 2025 in Journal of the American Society of Cytopathology
Verified
Journal Article
Open access
PPPossawat Peungkiatpairote
Possawat Peungkiatpairote
SCSayanan Chowsilpa
Sayanan Chowsilpa
The atypical category (AC) by the Yokohama system is an indeterminate group characterized by predominantly benign cytomorphology of the lesions, with some uncommon features that may be seen in malignancy in breast fine-needle aspiration. The risk of malignancy (ROM) varies from 13% to 25%. Its management depends on the clinical and radiological findings. Since most cases are benign, selecting cases for further management may benefit patients. This study aims to determine the clinicoradiological predictors for malignancy in AC breast cytology. All AC breast fine-needle aspirations at Chiang Mai University Hospital from 2015 to 2019 were selected from an electronic database for cyto-histological correlation and ROM calculation. The clinicoradiological factors calculated by ROM were analyzed using multivariable logistic regression for malignant prediction and screening scores. There were 218 aspirates from patients aged 15-77 years. The lesion size ranged from 0.2 to 9.2 cm. The ROM was 27.5%. The significant predictors were age ≥40 years (P = 0.03), lesion size ≥1 cm (P< 0.01), and suspicious calcification on imaging (P < 0.01). The ROM was numerically increased in Breast Imaging-Reporting and Data System 5. The screening score showed 88.3% sensitivity, 55.1% specificity, 42.7% positive predictive value, and 92.6% negative predictive value. The AC diagnosis varies from benign to malignant. Age ≥40 years, a lesion size ≥1 cm, and suspicious calcification/Breast Imaging-Reporting and Data System 5 are useful predictors of malignancy. Selecting cases according to screening scores can reduce invasive procedures by up to 43.1%.

28 December 2022 in Biomedical Sciences and Clinical Medicine
Verified
Journal Article
Open access
PDF file
CMChakri Madla
Chakri Madla
SASalita Angkurawaranon
Salita Angkurawaranon
HKHanpon Klibngern
Hanpon Klibngern
SCSayanan Chowsilpa
Sayanan Chowsilpa
OBJECTIVE To distinguish between benign lesions and malignant tumors of the parotid gland through physical examination and analysis of single-phase contrast-enhanced CT imaging.METHODS A retrospective study of parotid gland masses in adult patients (age > 15 years) at Maharaj Nakorn Chiang Mai Hospital from 2014 to 2021. Patient demographic data included gender, age and smoking history. Characteristics of parotid masses were established based on physical examinations including mass consistency, pain/tenderness, invasion of surrounding tissue including fixation, skin involvement, trismus and facial nerve palsy, as well as imaging findings indicating mass location, size, number, distribution, shape, margin, composition, extra-parenchymal extension and calcification.RESULTS A total of 78 patients (10 exhibiting bilateral parotid gland involvement) were diagnosed with a total of 44 benign lesions and 34 malignant tumors. Significant parameters for suspicion of malignancy were determined by two clinical examinations, hard consistency (odds ratio = 60.00, 95% CI = 4.72 to 763.01) and pain/tenderness (odds ratio = 7.45, 95% CI = 1.90 to 29.25) and four imaging findings composed of irregular shape (OR = 7.00, 95% CI = 1.69 to 28.92), ill-defined margins (OR = 10.15, 95% CI = 3.28 to 31.44), extra-parenchymal extension (OR = 32.50, 95% CI = 8.88 to 118.99) and calcification (OR = 6.97, 95% CI = 1.74 to 27.88).CONCLUSIONS Clinical examination and findings obtained from single-phase contrast-enhanced CT scans can help to distinguish benign from malignant parotid masses.


9 April 2025 in Cytojournal
Verified
Journal Article
Open access
KWKomson Wannasai
Komson Wannasai
SKSarawut Kongkarnka
Sarawut Kongkarnka
NLNirush Lertprasertsuke
Nirush Lertprasertsuke
PPPhichayut Phinyo
Phichayut Phinyo
CNChindanai Namwong
Chindanai Namwong
SCSayanan Chowsilpa
Sayanan Chowsilpa
Objective: This study investigates the diagnostic concordance between bronchoalveolar lavage (BAL) cytology and the histologic analysis of transbronchial lung biopsy (TBLB) specimens in patients with suspected pulmonary diseases to highlight the strengths and limitations of these complementary diagnostic tools. Material and Methods: We conducted a comprehensive retrospective cross-sectional analysis on patients suspected of pulmonary diseases who underwent both BAL and TBLB from 2018 to 2022. We assessed diagnostic agreement using kappa statistics and calculated the overall concordance rates. The analysis was stratified based on malignant versus infectious etiologies to elucidate performance differences between the two methods. Results: Our study included a cohort of 189 patients, comprising 104 individuals with suspected malignancy and 85 with suspected infections. Among the malignancy group, BAL yielded positive results for cancer in 49 patients, whereas TBLB confirmed malignancy in 64 patients, demonstrating an overall agreement of 70.19% (kappa = 0.52, 95% confidence interval [CI]: 0.38–0.66). Conversely, within the infectious cohort, BAL identified micro-organisms in only five patients, while TBLB diagnosed infection in 22 patients, achieving an overall agreement of 77.65% (kappa = 0.29, 95% CI: 0.17–0.41). Conclusion: Our findings underscore the critical role of BAL cytology in the diagnosis of pulmonary carcinoma and infectious processes while also revealing its limitations in detecting interstitial lung diseases. The TBLB procedure emerges as an indispensable technique for accurate histopathological evaluation in lung cancer diagnostics. The integration of BAL and TBLB not only enhances diagnostic yield but also provides a more comprehensive understanding of pulmonary pathologies. Notably, we found moderate agreement between BAL and TBLB in neoplastic cases and fair agreement in non-neoplastic conditions, suggesting a nuanced interplay between these methodologies that could inform clinical practice and improve patient outcomes. This study advocates a combined approach in diagnostic frameworks to optimize the management of patients with suspected pulmonary diseases, paving the way for more precise and effective diagnoses in the field of cytology.